Cancer Research AACR Conference on Molecular Diagnostics - 2008  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 40, 3211-3213, September 1, 1980]
© 1980 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brunda, M. J.
Right arrow Articles by Minden, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brunda, M. J.
Right arrow Articles by Minden, P.

Immunotherapy of the Guinea Pig Line 10 Hepatocarcinoma with a Variety of Nonviable Bacteria1

Michael J. Brunda2, Herbert L. Mathews3, H. Rodney Ferguson4, J. Kenneth McClatchy and Percy Minden5

National Jewish Hospital and Research Center, Denver, Colorado 80206

A variety of heat-killed bacteria were tested for their capacity to induce regressions of established line 10 hepatocarcinomas in syngeneic guinea pigs. Multiple intralesional injections of heat-killed Escherichia coli, Streptococcus mutans, Listeria monocytogenes, and Propionibacterium acnes resulted in complete regression of the tumor in a majority of guinea pigs. Repeated injections of heat-killed Mycobacterium bovis strain Bacillus Calmette-Guérin caused no regressions. Surviving animals were immune to subsequent challenge with line 10 cells but not L2C cells, another syngeneic tumor.

1 Supported by Grant CA-15446 awarded by the National Cancer Institute, Department of Health, Education and Welfare.

2 Recipient of Fellowship CA-05533 awarded by the National Cancer Institute, Department of Health, Education and Welfare. Present address: Laboratory of Immunodiagnosis, National Cancer Institute, Bethesda, Md. 20205.

3 Recipient of Fellowship CA-06362 awarded by the National Cancer Institute, Department of Health, Education and Welfare.

4 Recipient of Fellowship CA-05214 awarded by the National Cancer Institute, Department of Health, Education and Welfare. Present address: Department of Surgery, Kansas State University, Manhattan, Kans. 66502.

5 To whom requests for reprints should be addressed, at Department of Medicine, National Jewish Hospital and Research Center, 3800 East Colfax Avenue, Denver, Colo., 80206.

Received 2/ 7/80. Accepted 6/ 9/80.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1980 by the American Association for Cancer Research.